IL6 and COVID-19: Thus, it is reasonable to hypothesize that, albeit high IL-6 and glycemia levels might both simply sense an increased severity of COVID-19, the pro-inflammatory effect of glycemia could eventually hamper the effect of anti-inflammatory biologicals.